Longer survival of advanced cancer patients given methylnaltrexone for constipation suggests role for mu opiate receptor in cancer progression

Opioid painkillers and their receptor in cells -- the mu opiate receptor -- could be involved in cancer progression, and could thus be a target for treatments, a study of advanced cancer patients suggests.
Source: ScienceDaily Headlines - Category: Science Source Type: news